The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $5.71

Today's change+0.04 +0.71%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $5.71

Today's change+0.04 +0.71%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

China Cord Blood Corp up (U.S.)$0.04

China Cord Blood Corp closed up Friday by (U.S.)$0.04 or 0.71% to (U.S.)$5.71. Over the last five days, shares have lost 2.56% and are down 10.36% for the last year to date. This security has outperformed the S&P 500 by 29.42% during the last year.

Key company metrics

  • Open(U.S.) $5.77
  • Previous close(U.S.) $5.67
  • High(U.S.) $5.79
  • Low(U.S.) $5.65
  • Bid / Ask-- / --
  • YTD % change-10.36%
  • Volume60,734
  • Average volume (10-day)77,226
  • Average volume (1-month)124,228
  • Average volume (3-month)114,527
  • 52-week range(U.S.) $4.60 to (U.S.) $7.69
  • Beta0.61
  • Trailing P/E33.00×
  • P/E 1 year forward38.07×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.17
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX2.43%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue165163167152
Total other revenue--------
Total revenue165163167152
Gross profit129129131122
Total cost of revenue37343630
Total operating expense1171139995
Selling / general / administrative78766062
Research & development2322
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income48506857
Interest income (expense), net non-operating-26-25-26-25
Gain (loss) on sale of assets--------
Other--------
Income before tax28294737
Income after tax13173427
Income tax, total15121410
Net income14173327
Total adjustments to net income---8----
Net income before extra. items14173327
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1493327
Inc. avail. to common incl. extra. items1493327
Diluted net income1493327
Dilution adjustment--------
Diluted weighted average shares73737373
Diluted EPS excluding extraordinary itemsvalue per share0.190.120.460.37
Dividends per sharevalue per share--------
Diluted normalized EPSvalue per share0.190.120.460.37